{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:00:04Z","timestamp":1791446404363,"version":"4.3.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major Science and Technology Projects in Henan Province, Innovation Research on Antibody and Protein-based Drugs","award":["241110310100"],"award-info":[{"award-number":["241110310100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"DOI":"10.1186\/s12915-025-02398-2","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:20:24Z","timestamp":1759148424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Design and development of a bispecific antibody targeting BAFF and IL-17 for systemic lupus erythematosus treatment"],"prefix":"10.1186","volume":"23","author":[{"given":"Cheng","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2398_CR1","doi-asserted-by":"crossref","unstructured":"Wang FQ, Dang X, Yang WL. Transcriptomic studies unravel the molecular and cellular complexity of systemic lupus erythematosus: A review. Clin Immunol. 2024;268:110367.","DOI":"10.1016\/j.clim.2024.110367"},{"key":"2398_CR2","doi-asserted-by":"crossref","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.","DOI":"10.1038\/nrdp.2016.39"},{"key":"2398_CR3","doi-asserted-by":"crossref","unstructured":"Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, Hashim T, et al. An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus J Med Science. 2022;14(10):e30330.","DOI":"10.7759\/cureus.30330"},{"key":"2398_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gene.2018.05.041","volume":"668","author":"GN Goulielmos","year":"2018","unstructured":"Goulielmos GN, Zervou MI, Vazgiourakis VM, Ghodke-Puranik Y, Garyfallos A, Niewold TB. The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry. Gene. 2018;668:59\u201372.","journal-title":"Gene"},{"key":"2398_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107028","author":"SHT Luo","year":"2020","unstructured":"Luo SHT, Long H, Lu QJ. Recent advances in understanding pathogenesis and therapeutic strategies of systemic lupus erythematosus. Int Immunopharmacol. 2020. https:\/\/doi.org\/10.1016\/j.intimp.2020.107028.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"2398_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/19420862.2019.1624463","volume":"11","author":"RJ Benschop","year":"2019","unstructured":"Benschop RJ, Chow CK, Tian Y, Nelson J, Barmettler B, Atwell S, et al. Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. MAbs. 2019;11(6):1175\u201390.","journal-title":"MAbs"},{"key":"2398_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102736","author":"T M\u00f6ckel","year":"2021","unstructured":"M\u00f6ckel T, Basta F, Weinmann-Menke J, Schwarting A. B cell activating factor (BAFF): structure, functions, autoimmunity and clinical implications in systemic lupus erythematosus (SLE). Autoimmun Rev. 2021. https:\/\/doi.org\/10.1016\/j.autrev.2020.102736.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2398_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2014.05.004","volume":"154","author":"JC Martin","year":"2014","unstructured":"Martin JC, Baeten DL, Josien R. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clin Immunol. 2014;154(1):1\u201312.","journal-title":"Clin Immunol"},{"issue":"11","key":"2398_CR9","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","volume":"189","author":"P Schneider","year":"1999","unstructured":"Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189(11):1747\u201356.","journal-title":"J Exp Med"},{"issue":"7","key":"2398_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nri844","volume":"2","author":"F Mackay","year":"2002","unstructured":"Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2(7):465\u201375.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2398_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/08830185.2016.1276903","volume":"36","author":"E Samy","year":"2017","unstructured":"Samy E, Wax S, Huard B, Hess H, Schneider P. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases. Int Rev Immunol. 2017;36(1):3\u201319.","journal-title":"Int Rev Immunol"},{"issue":"1","key":"2398_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/prd.12083","volume":"69","author":"C Zenobia","year":"2015","unstructured":"Zenobia C, Hajishengallis G. Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000. 2015;69(1):142\u201359.","journal-title":"Periodontol 2000"},{"issue":"3","key":"2398_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/cmi.2010.21","volume":"7","author":"S Xu","year":"2010","unstructured":"Xu S, Cao XT. Interleukin-17 and its expanding biological functions. Cell Mol Immunol. 2010;7(3):164\u201374.","journal-title":"Cell Mol Immunol"},{"key":"2398_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep20651","author":"P L\u00f3pez","year":"2016","unstructured":"L\u00f3pez P, Rodr\u00edguez-Carrio J, Caminal-Montero L, Mozo L, Su\u00e1rez A. A pathogenic IFN\u03b1, BLyS and IL-17 axis in systemic lupus erythematosus patients. Sci Rep. 2016. https:\/\/doi.org\/10.1038\/srep20651.","journal-title":"Sci Rep"},{"key":"2398_CR15","doi-asserted-by":"crossref","unstructured":"Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B, et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus (vol 10, pg 778, 2009). Nat Immunol. 2014;15(9):894.","DOI":"10.1038\/ni0914-894a"},{"issue":"10","key":"2398_CR16","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1016\/S2665-9913(24)00278-9","volume":"6","author":"J Thorley","year":"2024","unstructured":"Thorley J. Belimumab and rituximab for SLE. Lancet Rheumatol. 2024;6(10):e666-e.","journal-title":"Lancet Rheumatol"},{"key":"2398_CR17","doi-asserted-by":"crossref","unstructured":"Abid N, Manaye S, Naushad H, Cheran K, Murthy C, Bornemann EA, et al. The Safety and Efficacy of Rituximab and Belimumab in Systemic Lupus Erythematosus: A Systematic Review. Cureus J Med Science. 2023;15(6):e40719.","DOI":"10.7759\/cureus.40719"},{"issue":"2","key":"2398_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2249.2009.03944.x","volume":"157","author":"A Nalbandian","year":"2009","unstructured":"Nalbandian A, Crisp\u00edn JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol. 2009;157(2):209\u201315.","journal-title":"Clin Exp Immunol"},{"key":"2398_CR19","doi-asserted-by":"crossref","unstructured":"Crisp\u00edn JC, Kyttaris VC, Tsokos GC. The Role of Interleukin-17 in Systemic Lupus Erythematosus. Th 17 Cells Health Dis. 2011:391\u2013400.","DOI":"10.1007\/978-1-4419-9371-7_20"},{"issue":"2","key":"2398_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/19420862.2016.1268307","volume":"9","author":"U Brinkmann","year":"2017","unstructured":"Brinkmann U, Kontermann RE. The making of bispecific antibodies. MAbs. 2017;9(2):182\u2013212.","journal-title":"MAbs"},{"key":"2398_CR21","doi-asserted-by":"crossref","unstructured":"Fan GW, Wang ZJ, Hao MJ, Li JM. Bispecific antibodies and their applications. J Hematol Oncol. 2015;8:130.","DOI":"10.1186\/s13045-015-0227-0"},{"issue":"4","key":"2398_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.blre.2018.02.004","volume":"32","author":"A Thakur","year":"2018","unstructured":"Thakur A, Huang M, Lum LG. Bispecific antibody based therapeutics: strengths and challenges. Blood Rev. 2018;32(4):339\u201347.","journal-title":"Blood Rev"},{"issue":"2","key":"2398_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molimm.2015.01.003","volume":"67","author":"C Spiess","year":"2015","unstructured":"Spiess C, Zhai QT, Carter PJ. Alternative molecular formats and therapeutic applications for bispecific antibodies. Mol Immunol. 2015;67(2):95\u2013106.","journal-title":"Mol Immunol"},{"key":"2398_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-131","author":"Y Karlen","year":"2007","unstructured":"Karlen Y, McNair A, Perseguers S, Mazza C, Mermod N. Statistical significance of quantitative PCR. BMC Bioinformatics. 2007. https:\/\/doi.org\/10.1186\/1471-2105-8-131.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"2398_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/15321819408013942","volume":"15","author":"GPS Raghava","year":"1994","unstructured":"Raghava GPS, Agrewala JN. Method for determining the affinity of monoclonal-antibody using noncompetitive Elisa - a computer-program. J Immunoassay. 1994;15(2):115\u201328.","journal-title":"J Immunoassay"},{"issue":"2","key":"2398_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bcp.2013.11.006","volume":"87","author":"DF Liang","year":"2014","unstructured":"Liang DF, Zeng QY, Xu ZG, Zhang H, Gui L, Xu C, et al. BAFF activates Erk1\/2 promoting cell proliferation and survival by Ca-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells. Biochem Pharmacol. 2014;87(2):332\u201343.","journal-title":"Biochem Pharmacol"},{"key":"2398_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-78","author":"DS Straus","year":"2013","unstructured":"Straus DS. TNF\u03b1 and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells. Mol Cancer. 2013. https:\/\/doi.org\/10.1186\/1476-4598-12-78.","journal-title":"Mol Cancer"},{"issue":"1","key":"2398_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ni1547","volume":"9","author":"D Depoil","year":"2008","unstructured":"Depoil D, Fleire S, Treanor BL, Weber M, Harwood NE, Marchbank KL, et al. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol. 2008;9(1):63\u201372.","journal-title":"Nat Immunol"}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-025-02398-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12915-025-02398-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-025-02398-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:20:28Z","timestamp":1759148428000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-025-02398-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2398"],"URL":"https:\/\/doi.org\/10.1186\/s12915-025-02398-2","relation":{},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the guidelines of the Animal Ethics Committee of Zhengzhou University, and the study protocol was approved by the committee (Approval No. ZZUIRB2021-141).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}